(All fields required)
Please enter a valid email.
Please enter your name.
Showing 1 - 5 of 5 records.
This study will compare the effect of beta blocker therapy (Atenolol) to that of angiotensin II receptor blocker therapy (Losartan) on the rates of aortic growth and other cardiovascular outcomes....More
The congenital long QT syndrome (LQTS) is a heart disease that tends to occur among family members. LQTS patients are at increased risk of sudden cardiac (heart) death. There are three major subtypes, LQT1, LQT2 and LQT3. About 97% cardiac events in LQT1 patients are related to exercise, emotion...More
Cincinnati Children’s is conducting a research study to determine how many children adopted from Guatemala have Chagas disease. Chagas disease is caused by Trypanosoma cruzi. T. cruzi is a parasite that is found in parts of Central and South America, and Mexico. If left untreated, it can lead to h...More
The goal of this project, called Heart Institute BioRepository (HIBR), is to collect and store samples (such as blood, urine and tissues) that can be used by researchers to study and develop new ways to identify, treat and prevent childhood heart diseases and conditions. Limited personal informati...More
Cincinnati Children’s is conducting a research study, sometimes known as a clinical trial or clinical study, to learn if the drug Aldactone (spironolactone) slows down the process of scar formation in the heart in people with Duchenne Muscular Dystrophy (DMD)....More
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center